| Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy P Aggarwal, JB Hall, CB McLeland, MA Dobrovolskaia, SE McNeil Advanced drug delivery reviews 61 (6), 428-437, 2009 | 2051 | 2009 |
| Immunological properties of engineered nanomaterials MA Dobrovolskaia, SE McNeil Nature nanotechnology 2 (8), 469-478, 2007 | 2041 | 2007 |
| Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution MA Dobrovolskaia, P Aggarwal, JB Hall, SE McNeil Molecular pharmaceutics 5 (4), 487-495, 2008 | 1166 | 2008 |
| Minireview: nanoparticles and the immune system BS Zolnik, Á González-Fernández, N Sadrieh, MA Dobrovolskaia Endocrinology 151 (2), 458-465, 2010 | 1018 | 2010 |
| Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles MA Dobrovolskaia, AK Patri, J Zheng, JD Clogston, N Ayub, P Aggarwal, ... Nanomedicine: Nanotechnology, Biology and Medicine 5 (2), 106-117, 2009 | 801 | 2009 |
| Toll receptors, CD14, and macrophage activation and deactivation by LPS MA Dobrovolskaia, SN Vogel Microbes and Infection 4 (9), 903-914, 2002 | 717 | 2002 |
| Method for analysis of nanoparticle hemolytic properties in vitro MA Dobrovolskaia, JD Clogston, BW Neun, JB Hall, AK Patri, SE McNeil Nano letters 8 (8), 2180-2187, 2008 | 626 | 2008 |
| Characterization of nanoparticles for therapeutics JB Hall, MA Dobrovolskaia, AK Patri, SE McNeil Future Medicine Ltd 2 (6), 789-803, 2007 | 485 | 2007 |
| Evaluation of nanoparticle immunotoxicity MA Dobrovolskaia, DR Germolec, JL Weaver Nature nanotechnology 4 (7), 411-414, 2009 | 422 | 2009 |
| Induction of in vitro reprogramming by Toll-like receptor (TLR) 2 and TLR4 agonists in murine macrophages: effects of TLR “homotolerance” versus “heterotolerance” on NF-κB … MA Dobrovolskaia, AE Medvedev, KE Thomas, N Cuesta, V Toshchakov, ... The Journal of Immunology 170 (1), 508-519, 2003 | 389 | 2003 |
| Nanoparticles and the blood coagulation system. Part II: safety concerns AN Ilinskaya, MA Dobrovolskaia Nanomedicine 8 (6), 969-981, 2013 | 327* | 2013 |
| Mechanisms and barriers in cancer nanomedicine: addressing challenges, looking for solutions TJ Anchordoquy, Y Barenholz, D Boraschi, M Chorny, P Decuzzi, ... ACS nano 11 (1), 12-18, 2017 | 310 | 2017 |
| Current understanding of interactions between nanoparticles and the immune system MA Dobrovolskaia, M Shurin, AA Shvedova Toxicology and applied pharmacology 299, 78-89, 2016 | 286 | 2016 |
| Radioactive gold nanoparticles in cancer therapy: therapeutic efficacy studies of GA-198AuNP nanoconstruct in prostate tumor-bearing mice N Chanda, P Kan, LD Watkinson, R Shukla, A Zambre, TL Carmack, ... Nanomedicine in Cancer, 753-774, 2017 | 284 | 2017 |
| Understanding the correlation between in vitro and in vivo immunotoxicity tests for nanomedicines MA Dobrovolskaia, SE McNeil Journal of controlled release 172 (2), 456-466, 2013 | 284 | 2013 |
| Common pitfalls in nanotechnology: lessons learned from NCI's Nanotechnology Characterization Laboratory RM Crist, JH Grossman, AK Patri, ST Stern, MA Dobrovolskaia, ... Integrative Biology 5 (1), 66-73, 2013 | 271 | 2013 |
| Nanoparticle Size and Surface Charge Determine Effects of PAMAM Dendrimers on Human Platelets in Vitro MA Dobrovolskaia, AK Patri, J Simak, JB Hall, J Semberova, ... Molecular pharmaceutics 9 (3), 382-393, 2012 | 253 | 2012 |
| Identification and avoidance of potential artifacts and misinterpretations in nanomaterial ecotoxicity measurements EJ Petersen, TB Henry, J Zhao, RI MacCuspie, TL Kirschling, ... Environmental science & technology 48 (8), 4226-4246, 2014 | 248 | 2014 |
| Design and self-assembly of siRNA-functionalized RNA nanoparticles for use in automated nanomedicine KA Afonin, WW Grabow, FM Walker, E Bindewald, MA Dobrovolskaia, ... Therapeutic RNA Nanotechnology, 249-284, 2021 | 220 | 2021 |
| To PEGylate or not to PEGylate: Immunological properties of nanomedicine’s most popular component, polyethylene glycol and its alternatives D Shi, D Beasock, A Fessler, J Szebeni, JY Ljubimova, KA Afonin, ... Advanced drug delivery reviews 180, 114079, 2022 | 203 | 2022 |
Kirill AfoninProfessor of Chemistry at UNC CharlotteVerified email at uncc.edu
